Qualcomm expects at least $4.5B as part of its settlement from Apple

By Nikita Chaurasia  Date: 2019-05-03

Qualcomm expects at least $4.5B as part of its settlement from Apple
  • Both the companies had been locked in an unpleasant patent dispute since the last few years.
     
  • The multibillion-dollar payment stands out to be a big victory for Qualcomm.

The U.S.-based multinational telecommunications equipment company Qualcomm has reportedly announced that it hopes to receive at least $4.5 billion from its settlement agreement with the American technology giant Apple Inc. For those uninitiated, both the companies had been locked in an unpleasant patent dispute since the last few years.

As per authentic sources, last month Apple and Qualcomm ended a long-standing, major patent and antitrust case, which had commenced when Apple had sued the latter for suspected unfair practices of patent licensing for about $1 billion. The dispute took an ugly turn when Qualcomm had filed a countersuit for around $7 billion. Qualcomm turned out to be the apparent winner, attaining a 6-year licensing deal & a chip supply agreement, along with the major one-off payment.  

The multibillion-dollar payment stands out to be a big victory for Qualcomm, which has mentioned in its quarterly earnings report, its expectations to gain a total of $4.7 billion to around $5.5 billion in regular revenue over the upcoming quarter. The company said that its legal war is not significantly an immediate game changer, although the deal has positioned the firm to be the sole 5G modem supplier of Apple, given Intel’s withdrawal from the market.

According to the Qualcomm Chief Executive, Steven Mollenkopf, the rest of the fiscal year is estimated to be affected by a slower market for devices specifically in China, which is upstream of the greater global rollouts of 5G. While, Chief Financial Officer David Wise lowered the estimate of Qualcomm for the 2019 communications-chip shipments by around 50 million units, given the market weakness in China and an expansion of the handset replacement recycle, which potentially reflects a pause ahead of 5G rollouts.

Source Credits: https://www.theverge.com/2019/5/1/18525962/qualcomm-apple-settlement-4-5-billion-dollars-patent

https://gizmodo.com/qualcomm-scored-4-5-billion-or-more-in-settlement-with-1834461996

https://www.marketwatch.com/story/apple-deal-doesnt-solve-qualcomms-problems-2019-05-01

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...